ARTICLE | Company News
Guilford, MAP Dopascan deal
January 2, 2002 8:00 AM UTC
GLFD licensed exclusive European development, marketing and distribution rights for its Dopascan imaging agent for Parkinson's disease to MAP Medical Technologies (Tikkakoski, Finland). GLFD will rece...